Creatine vs BCAAs — which actually builds muscle?
Both sit on the same shelf at every supplement store, both are pitched at the same lifter, and both promise more muscle. Only one delivers consistently. Creatine monohydrate is one of the most-studied supplements in human history (Tier 1, evidence score 5/5 in our database). BCAAs as a standalone product are a Tier 2 supplement with weak independent evidence (2/5) — most of their headline benefits disappear once you control for adequate total protein intake.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Strength & muscle mass | Creatine | 500+ RCTs; reliably increases lean mass by 1–2 kg and 1RM strength by 5–10% over 8–12 weeks. BCAAs do not outperform whey, casein, or any protein source matching the equivalent leucine load. |
| Reducing perceived soreness (DOMS) | BCAAs (modestly) | Small reduction in DOMS scores in some trials, but effect disappears when total protein is adequate. Not worth the price if you already eat 1.6 g/kg/day protein. |
| Cognition / brain energy | Creatine | Emerging evidence for working memory, mood under sleep deprivation, and recovery from concussion. BCAAs have no comparable cognitive RCT base. |
| Fasted training preservation | BCAAs (niche only) | Theoretically helpful if training fasted with no other amino source. EAA blends are a better-evidenced alternative. |
| Cost per effective dose | Creatine | Roughly $0.10/day for 5 g monohydrate. BCAAs run $0.50–1.00/day for a typical 7–10 g serving. |
How they compare on the things that matter
Mechanism — what they actually do
Creatine works by saturating the phosphocreatine pool in muscle. Higher PCr stores let the ATP-PCr energy system recycle ATP faster during short, high-intensity efforts — meaning one or two extra reps per set, slightly higher peak power, and a small intracellular water shift that contributes to lean-mass gains. The effect is mechanical and measurable.
BCAAs (leucine, isoleucine, valine) are the three amino acids most directly involved in triggering muscle protein synthesis (MPS) via the mTORC1 pathway, with leucine doing most of the work. The catch is that MPS also requires the other six essential amino acids to actually build a complete protein — supplying just three forces the body to draw the rest from its own tissue, capping the effect. This is why head-to-head trials of BCAAs versus complete protein sources consistently favour the complete protein.
Evidence base
- Creatine — Tier 1. The 2024 Xu et al. systematic review (16 RCTs, 492 participants) confirms supplementation increases strength and lean mass across age and training-status groups. The 2003 Kreider/ISSN position stand and its 2017 update remain authoritative; both conclude monohydrate at 3–5 g/day is the most studied, most cost-effective form.
- BCAAs — Tier 2. The Wolfe 2017 review concluded BCAAs alone cannot maximally stimulate MPS; complete-protein controls outperform them in every direct comparison. A 2023 meta-analysis on resistance-trained adults found no significant lean-mass advantage for BCAA over placebo when total protein intake was matched.
Safety and side-effects
Creatine has the cleanest long-term safety record of any performance supplement studied. Decades of trials show no adverse effects on kidney function in healthy adults, no hair-loss signal that has held up to controlled testing, and only minor GI complaints at the 20 g/day loading phase (which is itself optional — a flat 5 g/day reaches saturation in 3–4 weeks).
BCAAs are also safe at typical doses but interact with other amino acids. High BCAA intakes can suppress tryptophan uptake into the brain, which a handful of small trials suggest may modestly reduce serotonergic mood effects. Long-term very-high BCAA intakes have been linked in epidemiological work to insulin resistance signals, though the supplemental dose range is well below those exposures.
What the price difference buys you
Creatine monohydrate costs roughly $20–30 for a 60-day supply at 5 g/day. BCAA powders typically cost $30–50 for a 30-day supply, often with proprietary flavour systems and "performance" branding inflating the price. Per dollar of measurable benefit, creatine is roughly 10× more cost-effective for the muscle-building goal.
Who should skip each
Creatine should be used cautiously in people with significant pre-existing kidney disease (eGFR < 60 — discuss with a clinician), and during the first few weeks the small water shift can add 0.5–1.5 kg on the scale, which weight-class athletes should anticipate. Otherwise it has essentially universal applicability.
BCAAs in supplemental form are simply unnecessary for most people meeting protein intake targets through diet. They should not be used in maple syrup urine disease (a rare metabolic disorder), and they're a wasteful purchase for anyone already drinking a whey or plant protein shake.
What we'd actually buy
For strength, hypertrophy, and most cognitive endpoints: 5 g/day creatine monohydrate (skip the loading phase unless you need saturation in <2 weeks), taken at any time, with or without food. Cheap unflavoured monohydrate is identical in efficacy to expensive "buffered" or "HCl" forms — the patents on those are marketing, not chemistry.
For total amino acid coverage during fasted training: an EAA blend at 10–15 g, not a BCAA-only product. Or simply 25–30 g of whey protein, which delivers the same leucine threshold plus the rest of the amino acid pool.
Sources
- Xu C, et al. Effects of creatine supplementation on resistance training performance: a systematic review and meta-analysis. Sports Med. 2024. PMID: 39070254
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation. JISSN. 2017;14:18. PMID: 28615996
- Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? JISSN. 2017;14:30. PMID: 28852372
- Antonio J, et al. Common questions and misconceptions about creatine supplementation. JISSN. 2021;18:13. PMID: 33557850
- Plotkin DL, et al. Isolated leucine and BCAA supplementation for enhancing muscular strength and hypertrophy. Front Physiol. 2021;12:759588. PMID: 34764890
- Candow DG, et al. Creatine supplementation and aging musculoskeletal health. Endocrine. 2014;45:354–61. PMID: 24190049